No Data
No Data
Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Manage Its Debt Responsibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n
Insider Sale: CFO, EVP & Treasurer William Peters Sells Shares of Amphastar Pharmaceuticals ...
Amphastar Pharmaceuticals(AMPH.US) Officer Sells US$147.17K in Common Stock
$Amphastar Pharmaceuticals(AMPH.US)$ Officer PETERS WILLIAM J sold 3,596 shares of common stock on Jun 27, 2024 at an average price of $40.9258 for a total value of $147.17K.Source: Announcement What
Form 144 | Amphastar Pharmaceuticals(AMPH.US) Officer Proposes to Sell 144.56K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 27, $Amphastar Pharmaceuticals(AMPH.US)$ Officer PETERS WILLIAM J intends to sell 3,596 shares of its common stock on Jun 27, with a total market value of approximately $14
Amphastar Pharmaceuticals Price Target Maintained With a $71.00/Share by Piper Sandler
Amphastar Pharmaceuticals Price Target Maintained With a $71.00/Share by Piper Sandler
Piper Sandler Reiterates Overweight on Amphastar Pharma, Maintains $71 Price Target
Piper Sandler analyst David Amsellem reiterates Amphastar Pharma (NASDAQ:AMPH) with a Overweight and maintains $71 price target.